Mandate

Vinge advises Agnico Eagle in connection with its acquisition of a majority stake in and joint venture regarding Gunnarn Mining AB

June 18, 2015 M&A

Vinge advises Agnico Eagle Mines Limited in connection with its acquisition of a 55% interest in Gunnarn Mining AB, the owner of the Barsele Gold Project, from Orex Minerals Inc. for US $10 million and the entering into of a joint venture agreement for the management and operation of Gunnarn Mining AB and the exploration and development of the Barsele project. As part of the transaction, Agnico Eagle granted a royalty interest in the project to Orex, has committed to spend US $7 million over three years and will earn an additional 15% interest in Gunnarn Mining AB if it completes a pre-feasibility study. The transaction was completed on 11 June 2015.

Vinge advises Agnico Eagle on Swedish law matters and in co-operation with Davies Ward Phillips & Vineberg LLP. Vinge’s team consists of M&A partners Malin Ohlin and Peter Sundgren, associates Kajsa Hallner (M&A), Isabell Nielsen (commercial agreements), Lova Unge (employment and benefits), Tora Hansjons (tax) and counsels Maria Schultzberg (tax) and Johan Cederblad (real estate and environment).

 

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026